CHINARES PHARMA (03320) subsidiary China Resources Double-Crane Pharmaceutical has been approved to issue corporate bonds totaling 3 billion yuan.
China Resources Pharmaceutical (03320) announced that its non-wholly-owned subsidiary, China Resources Double-Crane Pharmaceutical Co., Ltd. (China Resources Double-Crane), has received a registration approval notice (CSRC License [2026] No. 118) from the China Securities Regulatory Commission for its proposed issuance of corporate bonds to qualified investors in the People's Republic of China (China). The notice is valid for 24 months from the date of issuance, during which China Resources Double-Crane can issue corporate bonds with a total amount of 3 billion yuan in installments.
CHINARES PHARMA (03320) announces that its non-wholly owned subsidiary China Resources Double-Crane Pharmaceutical Co., Ltd. (China Resources Double-Crane Pharmaceutical) has received a registration approval notice (CSRC License [2026] No. 118) from the China Securities Regulatory Commission for the proposed issuance of corporate bonds by China Resources Double-Crane Pharmaceutical to qualified investors in the People's Republic of China. The notice is valid for 24 months from the date of issuance, during which China Resources Double-Crane Pharmaceutical may issue corporate bonds in installments totaling RMB 3 billion.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
